Submission of application to the MPA

  • 10:40

Immunicum submits an application to the Medical Products Agency to receive regulatory approval for initiation of its first clinical phase I/II-trial in renal cell carcinoma.


Deprecated: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4913

Comments are closed.